Robert L. Coffman

Active 1971–2025

152
Papers
71,157
Citations
112
h-index
151
i10-index

Citations

Citations per year for Robert L. Coffman1896: 1 citations1972: 1 citations1973: 2 citations1974: 1 citations1975: 1 citations1976: 1 citations1977: 5 citations1978: 4 citations1979: 3 citations1980: 2 citations1981: 8 citations1982: 7 citations1983: 16 citations1984: 21 citations1985: 40 citations1986: 79 citations1987: 148 citations1988: 203 citations1989: 282 citations1990: 256 citations1991: 381 citations1992: 392 citations1993: 577 citations1994: 520 citations1995: 592 citations1996: 611 citations1997: 629 citations1998: 808 citations1999: 759 citations2000: 655 citations2001: 605 citations2002: 675 citations2003: 675 citations2004: 681 citations2005: 594 citations2006: 662 citations2007: 656 citations2008: 691 citations2009: 688 citations2010: 674 citations2011: 567 citations2012: 550 citations2013: 541 citations2014: 468 citations2015: 418 citations2016: 334 citations2017: 343 citations2018: 330 citations2019: 1,055 citations2020: 1,012 citations2021: 1,149 citations2022: 812 citations2023: 546 citations2024: 741 citations2025: 340 citations2026: 9 citations1897–1971: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,208 citing papers, 34.9% of this breakdownUnited Kingdom: 1,688 citing papers, 7.2% of this breakdownChina: 1,587 citing papers, 6.7% of this breakdownGermany: 1,433 citing papers, 6.1% of this breakdownJapan: 1,145 citing papers, 4.9% of this breakdownFrance: 939 citing papers, 4% of this breakdownItaly: 825 citing papers, 3.5% of this breakdownCanada: 790 citing papers, 3.4% of this breakdownAustralia: 639 citing papers, 2.7% of this breakdownNetherlands: 570 citing papers, 2.4% of this breakdownSwitzerland: 522 citing papers, 2.2% of this breakdownBrazil: 377 citing papers, 1.6% of this breakdown
0%34.9%Other 20.4%

Fields

  • Immunology and Microbiology44.1%
  • Medicine38.8%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Neuroscience1.9%
  • Agricultural and Biological Sciences1.4%
  • Dentistry0.5%
  • Other2.4%

Topics

  • Immune Cell Function and Interaction9.4%
  • T-cell and B-cell Immunology8.4%
  • Immunotherapy and Immune Responses6.3%
  • Immune Response and Inflammation4.8%
  • Asthma and respiratory diseases2.7%
  • IL-33, ST2, and ILC Pathways2.1%
  • Other66.3%

Coauthors

All papers

Open in search
  1. Interleukin-10 and the Interleukin-10 Receptor

    Authors: , , , - Annual Review of Immunology 2001 cited by 6,696

  2. Vaccine Adjuvants: Putting Innate Immunity to Work

    Authors: , , - Immunity 2010 cited by 1,915

  3. Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus

    Authors: , , , , , , , , , , , , - Science Translational Medicine 2011 cited by 1,368

  4. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

    Authors: , , , , - The Journal of Immunology 1986 cited by 7,504

  5. TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties

    Authors: , - Annual Review of Immunology 1989 cited by 7,598

  6. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Skye Spencer, Lara Doyle‐Meyers, Rudolph P. Bohm, Nicholas J. Maness, Chad J. Roy, Jessica A. Plante, Kenneth S. Plante, Alex Zhu, Matthew J. Gorman, Sally Shin, Xiaoying Shen, Jane Fontenot, Shakti Gupta, Derek T. O’Hagan, Robbert van der Most, Rino Rappuoli, Robert L. Coffman, David Novack, Jason S. McLellan, Shankar Subramaniam, David C. Montefiori, Scott D. Boyd, JoAnne L. Flynn, Galit Alter, François Villinger, Harry Kleanthous, Jay Rappaport, Mehul S. Suthar, Neil P. King, David Veesler, Bali Pulendran - Nature 2021 cited by 353

  7. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9

    Authors: , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 475

  8. SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

    Authors: , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 341

  9. Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer

    Authors: , , , , , , , , , , , , , , , , - JCI Insight 2017 cited by 287

  10. Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8 + T cells

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 227

  11. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

    Authors: , , , , , , , , - The Journal of Experimental Medicine 2005 cited by 920

  12. An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation

    Authors: , , , , - The Journal of Experimental Medicine 1999 cited by 1,588

  13. Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

    Authors: , , , , , - Immunity 1994 cited by 1,146

  14. In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma

    Authors: , , , , , , , , , , , - Cancer Discovery 2018 cited by 188

  15. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells

    Authors: , , , , , , - Nature 1988 cited by 947

  16. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

    Authors: , , , , , , , , , , , , , , - Nature 2010 cited by 374

  17. OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2015 cited by 223

  18. Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19

    Authors: , , , , , , , , , , , , , - Scientific Reports 2020 cited by 180

  19. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

    Authors: , , , , - International Immunology 1993 cited by 1,072

  20. RNA recognition by human TLR8 can lead to autoimmune inflammation

    Authors: , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 202

  21. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

    Authors: , , , - Nature Medicine 2007 cited by 862

  22. Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - npj Vaccines 2022 cited by 55

  23. Interleukin 4 causes isotype switching to IgE in T cell-stimulated clonal B cell cultures.

    Authors: , - The Journal of Experimental Medicine 1988 cited by 368

  24. Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center Response

    Authors: , , , , , , , , , - Immunity 2011 cited by 234